REACT: A phase II study of rindopepimut (CDX-110) plus bevacizumab (BV) in relapsed glioblastoma (GB)

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Reardon, DA; Vredenburgh, JJ; Desjardins, A; Steis, RG; Dunbar, EM; Chandramouli, NB; Rixe, O; Green, JA; Davis, TA; Sampson, JH

Published Date

  • May 20, 2012

Published In

Volume / Issue

  • 30 / 15

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Conference Name

  • 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Conference Location

  • Chicago, IL

Conference Start Date

  • June 1, 2012

Conference End Date

  • June 6, 2012